These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38688882)

  • 21. Brain atrophy and patch-based grading in individuals from the CIMA-Q study: a progressive continuum from subjective cognitive decline to AD.
    Marcotte C; Potvin O; Collins DL; Rheault S; Duchesne S
    Sci Rep; 2019 Sep; 9(1):13532. PubMed ID: 31537852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
    Cacciamani F; Tandetnik C; Gagliardi G; Bertin H; Habert MO; Hampel H; Boukadida L; Révillon M; Epelbaum S; Dubois B;
    J Alzheimers Dis; 2017; 59(2):753-762. PubMed ID: 28671134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.
    van Rooden S; van den Berg-Huysmans AA; Croll PH; Labadie G; Hayes JM; Viviano R; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2018; 66(3):1283-1294. PubMed ID: 30412485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease.
    Moradi E; Hallikainen I; Hänninen T; Tohka J;
    Neuroimage Clin; 2017; 13():415-427. PubMed ID: 28116234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer's disease: an 11-year follow-up study.
    Mazzeo S; Padiglioni S; Bagnoli S; Carraro M; Piaceri I; Bracco L; Nacmias B; Sorbi S; Bessi V
    Eur J Neurol; 2020 May; 27(5):894-899. PubMed ID: 32043740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.
    Racine AM; Touroutoglou A; Abrantes T; Wong B; Fong TG; Cavallari M; Travison TG; Gou Y; Marcantonio ER; Alsop DC; Jones RN; Inouye SK; Dickerson BC;
    J Alzheimers Dis; 2020; 75(1):187-199. PubMed ID: 32250290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
    Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.
    Verfaillie SCJ; Pichet Binette A; Vachon-Presseau E; Tabrizi S; Savard M; Bellec P; Ossenkoppele R; Scheltens P; van der Flier WM; Breitner JCS; Villeneuve S;
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):463-472. PubMed ID: 29735156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
    Charissé D; Erus G; Pomponio R; Gorges M; Schmidt N; Schneider C; Liepelt-Scarfone I; Riedel O; Reetz K; Schulz JB; Berg D; Storch A; Witt K; Dodel R; Kalbe E; Kassubek J; Hilker-Roggendorf R; Baudrexel S
    Neurobiol Aging; 2022 Jan; 109():31-42. PubMed ID: 34649002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.